2025年10月30日,和誉医药(港交所代码:02256.HK)2025研发日在上海成功举办。本次活动以“和力聚梦 誉创未来”为主题,汇聚了数十家国内外投资机构代表、临床专家和媒体人士,与和誉医药管理层及研发团队共话公司创新研发布局和临床进展。和誉医药创始人兼首席执行官徐耀昌博士在开场致辞中阐述了公司的创新研发战略。他表示,和誉医药持续致力于在肿瘤及其他疾病领域开发具有差异化的创新疗法,以满足中国...
Source Link2025年10月30日,和誉医药(港交所代码:02256.HK)2025研发日在上海成功举办。本次活动以“和力聚梦 誉创未来”为主题,汇聚了数十家国内外投资机构代表、临床专家和媒体人士,与和誉医药管理层及研发团队共话公司创新研发布局和临床进展。和誉医药创始人兼首席执行官徐耀昌博士在开场致辞中阐述了公司的创新研发战略。他表示,和誉医药持续致力于在肿瘤及其他疾病领域开发具有差异化的创新疗法,以满足中国...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.